DK3774745T3 - Krystal af en oxazolforbindelse - Google Patents
Krystal af en oxazolforbindelse Download PDFInfo
- Publication number
- DK3774745T3 DK3774745T3 DK19718465.8T DK19718465T DK3774745T3 DK 3774745 T3 DK3774745 T3 DK 3774745T3 DK 19718465 T DK19718465 T DK 19718465T DK 3774745 T3 DK3774745 T3 DK 3774745T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystal
- oxazole compound
- oxazole
- compound
- Prior art date
Links
- -1 OXAZOLE COMPOUND Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018072717 | 2018-04-04 | ||
| PCT/JP2019/014730 WO2019194211A1 (en) | 2018-04-04 | 2019-04-03 | Oxazole compound crystal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3774745T3 true DK3774745T3 (da) | 2024-06-17 |
Family
ID=66223774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19718465.8T DK3774745T3 (da) | 2018-04-04 | 2019-04-03 | Krystal af en oxazolforbindelse |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US11414391B2 (da) |
| EP (2) | EP3774745B1 (da) |
| JP (3) | JP7326295B2 (da) |
| KR (2) | KR102764726B1 (da) |
| CN (1) | CN111902402A (da) |
| AU (2) | AU2019249562B2 (da) |
| BR (1) | BR112020019377A2 (da) |
| CA (1) | CA3095866A1 (da) |
| DK (1) | DK3774745T3 (da) |
| EA (1) | EA202092393A1 (da) |
| ES (1) | ES2982586T3 (da) |
| FI (1) | FI3774745T3 (da) |
| HR (1) | HRP20240858T1 (da) |
| HU (1) | HUE066793T2 (da) |
| IL (2) | IL277730B2 (da) |
| LT (1) | LT3774745T (da) |
| MX (1) | MX2020010435A (da) |
| PH (1) | PH12020551605A1 (da) |
| PL (1) | PL3774745T3 (da) |
| PT (1) | PT3774745T (da) |
| SG (1) | SG11202009564TA (da) |
| SI (1) | SI3774745T1 (da) |
| TW (1) | TWI860993B (da) |
| WO (1) | WO2019194211A1 (da) |
| ZA (1) | ZA202006134B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118843463A (zh) | 2022-03-25 | 2024-10-25 | 大塚制药株式会社 | 创伤治疗用组合物 |
| CN115887463A (zh) * | 2022-12-27 | 2023-04-04 | 瑞石生物医药有限公司 | 一种含环酰胺化合物的药物组合物 |
| GB202306663D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Combination therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1954684T3 (da) | 2005-11-15 | 2014-06-30 | Otsuka Pharma Co Ltd | Oxazol forbindelse og farmaceutisk sammensætning. |
| WO2014034958A1 (en) * | 2012-08-30 | 2014-03-06 | Otsuka Pharmaceutical Co., Ltd. | Method for producing oxazole compound |
| TWI726027B (zh) * | 2015-12-28 | 2021-05-01 | 日商大塚製藥股份有限公司 | 軟膏 |
-
2019
- 2019-04-03 BR BR112020019377-1A patent/BR112020019377A2/pt unknown
- 2019-04-03 IL IL277730A patent/IL277730B2/en unknown
- 2019-04-03 KR KR1020207031251A patent/KR102764726B1/ko active Active
- 2019-04-03 HR HRP20240858TT patent/HRP20240858T1/hr unknown
- 2019-04-03 HU HUE19718465A patent/HUE066793T2/hu unknown
- 2019-04-03 SG SG11202009564TA patent/SG11202009564TA/en unknown
- 2019-04-03 KR KR1020257003493A patent/KR20250022254A/ko active Pending
- 2019-04-03 MX MX2020010435A patent/MX2020010435A/es unknown
- 2019-04-03 ES ES19718465T patent/ES2982586T3/es active Active
- 2019-04-03 US US17/044,892 patent/US11414391B2/en active Active
- 2019-04-03 CN CN201980022064.2A patent/CN111902402A/zh active Pending
- 2019-04-03 EP EP19718465.8A patent/EP3774745B1/en active Active
- 2019-04-03 IL IL315425A patent/IL315425A/en unknown
- 2019-04-03 LT LTEPPCT/JP2019/014730T patent/LT3774745T/lt unknown
- 2019-04-03 FI FIEP19718465.8T patent/FI3774745T3/fi active
- 2019-04-03 PT PT197184658T patent/PT3774745T/pt unknown
- 2019-04-03 EP EP24172132.3A patent/EP4400167A3/en active Pending
- 2019-04-03 JP JP2020539109A patent/JP7326295B2/ja active Active
- 2019-04-03 TW TW108111946A patent/TWI860993B/zh active
- 2019-04-03 AU AU2019249562A patent/AU2019249562B2/en active Active
- 2019-04-03 DK DK19718465.8T patent/DK3774745T3/da active
- 2019-04-03 SI SI201930776T patent/SI3774745T1/sl unknown
- 2019-04-03 PL PL19718465.8T patent/PL3774745T3/pl unknown
- 2019-04-03 CA CA3095866A patent/CA3095866A1/en active Pending
- 2019-04-03 WO PCT/JP2019/014730 patent/WO2019194211A1/en unknown
- 2019-04-03 EA EA202092393A patent/EA202092393A1/ru unknown
-
2020
- 2020-09-30 PH PH12020551605A patent/PH12020551605A1/en unknown
- 2020-10-02 ZA ZA2020/06134A patent/ZA202006134B/en unknown
-
2021
- 2021-12-03 JP JP2021196978A patent/JP2022037040A/ja active Pending
-
2022
- 2022-07-07 US US17/859,675 patent/US11840512B2/en active Active
-
2023
- 2023-10-03 JP JP2023171778A patent/JP2024001115A/ja active Pending
- 2023-10-31 US US18/498,894 patent/US20240076275A1/en active Pending
-
2024
- 2024-09-24 AU AU2024220015A patent/AU2024220015A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3810581T3 (da) | Krystalmodifikationer af odevixibat | |
| DK3596042T3 (da) | Krystalformer af aminolipider | |
| DK3713919T3 (da) | Krystallinske former af n-(4-(4-(cyclopropylmethyl)piperazin-1-carbonyl)phenyl)quinolin-8-sulfonamid | |
| DK3490398T3 (da) | Fremgangsmåde til anvendelse af et sæt vippeextensions | |
| DK3891145T3 (da) | Modulatorer af trex1 | |
| DK3279202T3 (da) | Krystal af 3,5-disubstitueret benzenalkynylforbindelse | |
| DK3833662T3 (da) | Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2- | |
| DK3618758T4 (da) | Fremgangsmåde til konstruktion af en dental komponent | |
| DK3636640T3 (da) | Krystal af heterocyclidenacetamidderivat | |
| DK3740475T3 (da) | Fremgangsmåde til fremstilling af somatostatinmodulatorer | |
| DK3513617T3 (da) | Håndtering af PDCP under genetablering af forbindelse | |
| DK3833665T3 (da) | Diazabicyclooctanoner som hæmmere af serin-beta-lactamaser | |
| DK3567245T3 (da) | Drift af vindmølle | |
| DK3927899T3 (da) | Nedvibrering af funderinger | |
| DK3759745T3 (da) | Dannelse af piezoelektriske anordninger | |
| DK3774745T3 (da) | Krystal af en oxazolforbindelse | |
| DK3529236T3 (da) | Krystalformer af eravacyclin | |
| DK3818047T3 (da) | Hidtil ukendte forbindelser til bekæmpelse af arthropoder | |
| DK3765440T3 (da) | Fremgangsmåde til fremstilling af n-alkyl-nitratoethylnitraminer | |
| DK3749673T3 (da) | Krystallinsk form af bictegravir-natrium | |
| DK3668835T3 (da) | Fremgangsmåde til fremstilling af en monothiocarbonatforbindelse | |
| DK3856928T3 (da) | Fremgangsmåde til karakterisering af modifikationer forårsaget af anvendelsen af designernukleaser | |
| DK3743064T3 (da) | Behandling af proteinuri | |
| DK3746279T3 (da) | Sammenkobling af formdele | |
| DK3544068T3 (da) | Fremgangsmåde til fremstilling af termoelektriske mikrokølere |